The Scientist

» Big Pharma and microbiology

Most Recent

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

image: Gene Jumped to All Three Domains of Life

Gene Jumped to All Three Domains of Life

By | December 1, 2014

By horizontal gene transfer, an antibacterial gene family has dispersed to a plant, an insect, several fungi, and an archaeon.

1 Comment

image: Microflora for Hire

Microflora for Hire

By | December 1, 2014

The guts of cows and termites harbor microbes that are renowned complex-carbohydrate digesters, but the human gastrointestinal tract has flora that just might measure up.

2 Comments

image: Polymerase Pieces

Polymerase Pieces

By | December 1, 2014

Researchers discover a new subunit of a bacterial RNA polymerase—as well as hints of its potential role in defending against viruses.

0 Comments

image: Virus Protects Mouse Gut

Virus Protects Mouse Gut

By | November 19, 2014

A murine norovirus appears to recover some of the functions of commensal bacteria in the guts of germ-free or antibiotic-treated mice.

1 Comment

image: Virus May Explain “Melting” Sea Stars

Virus May Explain “Melting” Sea Stars

By | November 19, 2014

Researchers discover a densovirus that is associated with sea star wasting disease.

0 Comments

image: Sealed With a Kiss

Sealed With a Kiss

By | November 17, 2014

A single intimate smooch can transfer upwards of 80 million bacteria.

0 Comments

image: Week in Review: November 10–14

Week in Review: November 10–14

By | November 14, 2014

Funding for African science; microbiome studies may have contamination worries; mind-controlled gene expression; DNA record keeper

0 Comments

image: DNA Extraction Kits Contaminated

DNA Extraction Kits Contaminated

By | November 11, 2014

Sequencing study reveals low levels of microbes in lab reagents that can create big problems for some microbiome studies.

1 Comment

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS